Literature DB >> 21885199

Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws?

Nicolau Conte Neto1, Alliny de Souza Bastos, Rosemary Adriana Chierici-Marcantonio, Elcio Marcantonio.   

Abstract

Bisphosphonate-related osteonecrosis of the jaws is a relevant side-effect of these drugs that has been generating a great concern through increasing reports, worldwide, of this bone necrosis. Among several BRONJ hypothetical co-factors that could play a role in BRONJ pathogenesis, rheumatoid arthritis (RA) has been included as a relevant risk factor for BRONJ; however, until now the relationship between these diseases has not been fully explained. Thus, the purpose of this paper is to establish hypothetical factors that could link these two diseases, considering mainly inflammatory components and the organism effects of medicines used to treat RA, particularly steroids and methotrexate (MTX).
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885199     DOI: 10.1016/j.mehy.2011.08.008

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw.

Authors:  Paul C Mathai; Neelam N Andrade; Neha Aggarwal; Shibani Nerurkar; Prathmesh Kapoor
Journal:  Oral Maxillofac Surg       Date:  2018-03-05

2.  Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.

Authors:  Yuichiro Fujieda; Mototsugu Doi; Takuya Asaka; Masahiro Ota; Ryo Hisada; Naoki Ohnishi; Michihiro Kono; Hiraku Kameda; Daigo Nakazawa; Masaru Kato; Olga Amengual; Masahiko Takahata; Shinsuke Yasuda; Yoshimasa Kitagawa; Tatsuya Atsumi
Journal:  J Bone Miner Metab       Date:  2020-02-19       Impact factor: 2.626

3.  Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study.

Authors:  Rafael Scaf de Molon; Chingyun Hsu; Olga Bezouglaia; Sarah M Dry; Flavia Q Pirih; Akrivoula Soundia; Fernando Queiroz Cunha; Joni Augusto Cirelli; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2016-05-04       Impact factor: 6.741

4.  Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.

Authors:  Márcio Diniz-Freitas; José-Luis López-Cedrún; Jacinto Fernández-Sanromán; Abel García-García; Javier Fernández-Feijoo; Pedro Diz-Dios
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

5.  Oral bisphosphonate related osteonecrosis of the jaw: a challenging adverse effect.

Authors:  Ilke Coskun Benlidayi; Rengin Guzel
Journal:  ISRN Rheumatol       Date:  2013-05-16

6.  Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model.

Authors:  Nian Jing Rao; Ru Qing Yu; Jing Yi Wang; Alexandra Helm; Li Wu Zheng
Journal:  Biomed Res Int       Date:  2019-09-22       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.